-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Acasti Pharma Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2021 to Q2 2024.
- Acasti Pharma Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$724K, a 151% decline year-over-year.
- Acasti Pharma Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$2.27M, a 76.4% increase year-over-year.
- Acasti Pharma Inc. annual Income Tax Expense (Benefit) for 2023 was -$1.83M, a 80.8% increase from 2022.
- Acasti Pharma Inc. annual Income Tax Expense (Benefit) for 2022 was -$9.54M, a 1373% decline from 2021.
- Acasti Pharma Inc. annual Income Tax Expense (Benefit) for 2021 was -$648K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)